Research Interest: Effects of different diets, Dietary factors and fatty acids (especially conjugated fatty acids) on health, Especially on the Cancer Risk.

Research Interest: Pharmacoepidemiology, Drug utilization and factors related, Appropriateness, Adherence to clinical guidelines, Effectiveness, Variability.

Research Interest: Organic Chemistry: Total Synthesis of Complex Natural Product, Computational Chemistry: Conformational Analysis, Molecular Modelling and Spectra Simulation. Natural Product Discovery: Isolation, Structural Elucidation, and Absolute Configuration Deter-mination of Natural Product.

Research Interest: Isolation and structure elucidation of natural products, Search for bioactive compounds, Antifungal, Anticancer and anti-inflammatory phytochemicals from traditional Chinese medicine (TCM) or other ethnic medicine (e.g. Tujia, Miao and so on);Chemical and pharmacological study of Chinese medicine; Quality control study of Chinese medicine.

After graduation I started to work at Medical University of Silesia, where I completed my PhD thesis on genetic polymorphisms in coronary artery disease. Selected risk factors for development of arterial ischemic stroke in children were also in the area of my scientific interests. Besides, I am also interested in diagnosis and treatment of other neurological disorders in children: schizencephaly, headache, epilepsy and cerebral palsy. Nine years ago, when I moved to the Department of Pharmaceutical Technology I started the research concerning the technology for the manufacturing and optimization of micro- and nanocarriers of active substances. In addition, I am involved in analyses of rheological parameters of semi-solid preparations.

Research Interest: developmental neurology, neuroscience, genetics, pharmaceutical technology, nanotechnology, biochemistry

Grants: I participated in a multi-center Polish scientific grant and in several academic grants. In 2017, I was a supervisor of a grant of Medical University of Silesia regarding the release of active substances from semi-solid bases.

List of Publications:
Selected articles of my authorship:
1. Beata Sarecka-Hujar, Ilona Kopyta. Poststroke epilepsy: current perspectives on diagnosis and treatment. Neuropsychiatr.Dis.Treat. 2019; Vol.15, p.95-103

2. Joanna Sordyl, Ilona Kopyta, Beata Sarecka-Hujar, Tomasz Francuz, Paweł Matusik, Ewa Małecka-Tendera. Lipid levels and selected biomarkers of vascular changes in children with idiopathic headaches - a preliminary report. Arch.Med.Sci. 2019; Vol.15, No.1, p.120-125

3. Beata Sarecka-Hujar, Andrzej Jankowski, Aneta Ostróżka-Cieślik, Radosław Balwierz, Anna Banyś, Renata Dyja, Dariusz Łukowiec, Dominik Marciniak, Janusz Pluta. Assessment of release of trimetazidine hydrochloride from orally disintegrating tablets (ODTs) prepared using different disintegrants. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.697-704

4. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Tomasz Krzykawski, Jagna Karcz, Anna Banyś, Andrzej Jankowski. Application of selected diffractive and microscopic methods to evaluate the physical state of drug and morphology of microspheres obtained by spray drying of furosemide with Eudragit L30 D-55. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.3, p.759-765

5. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek. Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta.analysis. Clin.Exp.Med. 2018; Vol.18, No.3, p.337-345. 

6. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar, Andrzej Jankowski. Physicochemical characteristics of furosemide incorporated Eudragit microspheres formulated by spray drying. Acta Pol.Pharm.-Drug Res. 2018; Vol.75, No.6, p.1369-1376

7. Beata Sarecka-Hujar, Radosław Balwierz, Aneta Ostróżka-Cieślik, Renata Dyja, Dariusz Łukowiec, Andrzej Jankowski. Scanning electron microscopy and X-ray energy dispersive spectroscopy - useful tools in the analysis of pharmaceutical products. J.Phys.: Conf.Series 2017; Vol.931, 012008, p.1-5

8. Andrzej Jankowski, Renata Dyja, Beata Sarecka-Hujar. Dermal and transdermal delivery of active substances from semisolid bases. Indian J.Pharmaceut.Sci. 2017; Vol.79, No.4, p.488-500

9. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. The use of nanotechnology in modern pharmacotherapy. In: Multifunctional systems for combined delivery, biosensing and diagnostics. / Editors: Alexandru Mihai Grumezescu, Amsterdam: Elsevier Inc., 2017, p. 139-158, ISBN: 978-0-323-52725-5

10. Aneta Ostróżka-Cieślik, Beata Sarecka-Hujar. Perspectives of the carbon nanoparticles use in cancer therapy and imaging. Post.Biol.Kom. 2017; T.44, nr 2, s.171-184

11. Dorota Raczkiewicz, Beata Sarecka-Hujar, Alfred Owoc, Iwona Bojar. Cognitive functions and serum cortisol concentration in perimenopausal and postmenopausal women working non-manually. Neuroendocrinol.Lett. 2017; Vol.38, No.4, p.269-274

12. Dorota Raczkiewicz, Alfred Owoc, Beata Sarecka-Hujar, Iwona Bojar. Pain involving the motor system and serum vitamin D concentration in postmenopausal women working in agriculture. Ann.Agric.Environ.Med. 2017; Vol.24, No.1, p.151-155

13. Beata Sarecka-Hujar, Ilona Kopyta, Michał Skrzypek, J. Sordyl. Association between the 20210G>A prothrombin gene polymorphism and arterial ischemic stroke in children and young adults - two meta-analyses of 3586 cases and 6440 control subjects in total. Pediatr.Neurol. 2017; Vol.69, p.93-101

14. Beata Sarecka-Hujar, Aneta Ostróżka-Cieślik, Anna Banyś. Determinants of telemedicine development in health care system. Ann.Acad.Med.Siles. 2016; Vol.70, s.214-219

15. Ilona Kopyta, Paweł Niemiec, Anna Balcerzyk, Ewa Emich-Widera, Ewa Pilarska, Karolina Pienczk-Recławowicz, Marek Kaciński, Janusz Wendorff, Tomasz Nowak, Tomasz Iwanicki, Beata Sarecka-Hujar, Iwona Żak. Fibrinogen alpha and beta gene polymorphisms in pediatric stroke - Case-control and family based study. Eur.J.Paediatr.Neurol.2015; Vol.19, No.2, p.176-180

16. Ilona Kopyta, Mikołaj Zimny, Beata Sarecka-Hujar. The role of biochemical risk factors in the etiology of AIS in children and adults. Int.J.Neurosci.2015; Vol.125, No.12, p.875-884

17. Anna Banyś, Beata Sarecka-Hujar, Andrzej Jankowski, Monika Zalewska. Impact of base type on diclofenac sodium release from semi-solid dosage forms. Ann.Acad.Med.Siles. 2014; Vol.68, No.1, s.1-8

18. Ilona Kopyta, Beata Sarecka-Hujar, Joanna Sordyl, Ryszard Sordyl. The role of genetic risk factors in arterial ischemic stroke in pediatric and adult patients: a critical review. Mol.Biol.Rep. 2014; Vol.41, No.7, p.4241-4251

19. Beata Sarecka-Hujar, Iwona Żak, Ewa Emich-Widera et al. Association analysis of the E-selectin 98G>T polymorphism and the risk of childhood ischemic stroke. Cell Biochem. Funct. 2010; 28: 591-596.

20. Ilona Kopyta, Beata Sarecka-Hujar, Ewa Emich-Widera et al. Association between lipids and fibrinogen levels and ischemic stroke in the population of the Polish children with arteriopathy and cardiac disorders. Wiad. Lek. 2010; 63:17-23.  

21. Zak I, Sarecka-Hujar B, Kopyta I et al. The T allele of the 677C>T polymorphism of methylenetetrahydrofolate reductase gene is associated with an increased risk of ischemic stroke in Polish children. J Child Neurol. 2009; 24: 1262-1267. 

22. Sarecka-Hujar B, Zak I, Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease. Clin Exp Med. 2009; 9: 117-124.

Research Interest: Molecular pharmacology, physiology and biology of G protein-coupled (heptahelical or seven transmembrane-spanning) receptors; Heart Failure; Cardiovascular Disease; Neurohormonal control of the Circulation; Adrenal Physiology and Pharmacology; Receptors for Adrenaline and Noradrenaline; Catecholamines; Receptors for Angiotensin II; Signal Transduction; Gene Therapy; Transgenic mice and rats; Aldosterone production regulation; Regulation of Adrenergic and Angiotensin Receptors; G protein-coupled receptor Kinases; Beta-Arrestins; Novel “Biased” G protein-coupled Receptor Ligands.

Research Interest: Therapeutic relevance of plant-derived compounds in the field of the gastrointestinal pathologies (IBD, cancer, etc.) and on the signal transduction mechanisms involved in their action.Moreover, Toxicological aspects of natural products are also studied.

Research Interest: Discovery and development of novel protein-protein interaction inhibitors of the Tumorigenic process,Spectrum of drug discovery efforts combining computer-aided drug design, lead Generation, SAR design, Organic Synthesis, Biochemical Assays, Cell Culture Assays and Pharmacology.

Research Interest: Pharmacology on Chinese Herb, Cognitive Pharmacology on Chinese Herb, Behavioral Pharmacology, Psychopharmacology, Neuropharmacology.

Research Interest: Biotechnology, Artificial Intelligence, Neuroscience, Stem Cell Biology, Tissue Engineering, Stem Cell, Regenerative Medicine, Biodegradation.

Research Interest: Abuse-Deterrent Formulations (Tamper-Resistant Pharmaceutical Dosage Forms) Gastric Retention, Oral Drug Delivery, Controlled Drug Delivery Systems and Technologies, Gels, Hydrogels, Alcogels, Pharmacy Compounding.

Research Interest: Natural Product Chemistry,Nanotechnology, Essential Oils, Nanobiotechnology, Antioxidants,Veterinary Medicine, Dermatology, Pharmacy, Medicinal and Pharmaceutical Chemistry, Thin Films and Nanotechnology, Medicinal Plants and Herbs, Plant Biotechnology, Antioxidant Activit, Polyphenols, Phenolic Compoun, DPP, Botan, Microbiology, Environmental Chemistry, Antioxidant Assays, Flavonoids, Biotechnology, Bioactivi, Phytochemicals,LC-MS, Medicinal Plants, Spectroscopy, Chromatography, Natural Products, Ethnomedicine, Natural Product Isolatio.

Research Interest: Medicinal Plants, Obtaining, Characterization and standardization of extracts, Testing their pharmacological Action, Testing antioxidant activity in vitro and in vivo, Analysis and  isolation of biologically active compounds (polyphenols, carotenoides, essential oils, terpenes, alkaloids), spectrometric and chromatographical analysis (HPLC, GC).

Research Interest: Cancer Diagnostics, Cancer Research, Clinical Trials, Ophthalmology, Business, Economic Genetics, Stem Cell Biology, Cell Biology, Translational Cancer Research, Business Ethics, Oncology, Molecular Biology.

J. Warren Salmon, Ph.D. is Professor of Health Policy and Administration, School of Public Health at the University of Illinois at Chicago (UIC). He was formerly a Professor in and Head of the Department of Pharmacy Administration, College of Pharmacy; Professor of Public Policy Analysis, College of Urban Planning and Public Affairs; and Professor of Medical Education, College of Medicine at UIC.  Professor Salmon's research interests have focused on the corporatization of medicine and pharmacy, managed care pharmacy, urban health care delivery, comparative health care systems, global pharmaceutical industry developments, alternative and complimentary medicines, and selected health policy issues.  He edited Alternative Medicines:  Popular and Policy Perspectives (Tavistock/Methuen/Routledge, 1984); (with Jeffrey W. Todd) The Corporatization of Health Care: A Two Day Symposium and Public Hearing (Illinois Public Health Association, 1988); (with Eberhard Goepel) Community Participation and Empowerment Strategies in Health Promotion, 7 volumes (Zentrum fuer Interdisziplinare Forschung, 1990); The Corporate Transformation of Health Care, Part I:  Issues and Directions (Baywood, 1990); The Corporate Transformation of Health Care, Part II:  Reflections and Implications (Baywood, 1994); and (with Linda Shapiro) Health Care for Chicagoans:  How Will Health System Integration Affect the Health of the Public?  (Health & Medicine Policy Research Group, 1995).

Research Interest: Health policy and planning; managed care pharmacy; urban health care; international health; pharmaceutical industry developments; community health promotion; public sector health services; corporatization of medicine and pharmacy.

List of Publications:

1.    Salmon, J.W. (2015). Time to revisit Medicare Part D?  American Health & Drug Benefits.  
2.    Salmon, J.W. & Liu, X. M. (2015, in review). Pervasive Stigma:  HIV/AIDS Epidemic in China.  International Journal of Health Services.
3.    Edlavitch, S.A. & Salmon, J.W. (2015). Towards an applied science of regulatory decision-making. Journal of Pharmacovigilance 3:2.
4.    Thompson, S.L. & Salmon, J.W. (2016, Book in preparation).  Corporatization:  The Medical Malpractice Insurance Crisis and the Loss of Physician Hegemony. 
5.    Sanchez, A.M.  & Salmon, J.W.  (2016, in preparation).  Evaluation of the pharmaceutical performance in the undertaking of professional functions in the Cuban health care sector. Journal of Managed Care Pharmacy.
6.    Thompson, S.L. & Salmon, J.W. (2016, in preparation).  The medical malpractice insurance crisis. International Journal of Health Services
7.    Salmon, J.W. & Aruru, M.V. (2016, in preparation).  Health Tourism to India: Challenges against resource competition to sustaining a viable public healthcare infrastructure for the local populace.  International Journal of Health Services
8.    Aruru, M.V., Salmon, J.W. & Brock, C.M. (2016, in review).  Development of the Pharmacy Inventory, Labeling, and Logistics (PILL) Project in Resource-poor Haiti. International Journal of Health Services
9.    Salmon, J.W. (2016, in preparation).  The global pharmaceutical industry confronts the 21st century.  International Journal of Health Planning & Management.
10.    Sanchez, A.M.  & Salmon, J.W.  (2014, in revision).  Cuban pharmacy as it transitions toward a pharmaceutical care model.  International Journal of Pharmacy Practice
11.    Salmon, J.W. (2014). Global Health Systems.  Journal of Pharmacovigilance. 2:3
12.    Salmon, J.W. & Aruru, M. (2016, in revision).  Privatization and health/medical tourism in their global trade context.  International Journal of Public Policy
13.    Thompson, S.L. & Salmon, J.W. (2014). Physician Strikes. Chest: Official Publication of the American College of Chest Physicians. November.
14.    Salmon, J.W. & Gutkin, D. (2015, in preparation). Japan’s pharmaceutical industry: New developments as it challenges the major global firms. Journal of Managed Care Pharmacy.
15.    Aruru, M., Salmon, J.W. & Douglas, G.W. (2014). Multiple Sclerosis in India: A qualitative study of access, adherence and other issues in Southern India. Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
16.    Aruru, M. & Salmon, J.W. (2014). Lessons learned from the Pharmacy pictogram labeling project in Haiti.  Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
17.    Salmon, J.W. (2013). Medicare Part D & the Federal Employees Benefit Program. American Health & Drug Benefits.   6(1):58.
18.    Salmon, J.W. & Jiang, R. (2013). E-Prescribing: History, Issues, and Potentials. Online Journal of Public Health Informatics 4(3).
19.    Aruru, M. V. & Salmon, J.W. (2013). Assessment of Medicare Part D communications to beneficiaries. American Health & Drug Benefits.  3(5):310-317.
20.    Qato, D., Salmon, J.W. & Lindau, S.T. (2015, in preparation). Racial and ethnic disparities in the use of prescription medications among older adults in the U.S.:  A Population-based approach. 
21.    Salmon, J.W. & Sanchez, A.M. (2012). Overview of Complementary/Alternative Medicine in the Cuban Health System, International Journal of Healing and Caring 13(1).
22.    Sanchez, A.M.  & Salmon, J.W.  (2012). Cuban pharmacy in the context of its healthcare system:  Transitioning toward pharmaceutical care practice.  Proceedings of the Business and Health Administration Association, Chicago, Illinois, March.
23.    Salmon, J.W. (2016, in preparation). Obamacare:  The dehiscence of the American health care delivery system.
24.    Salmon, J.W. (2014, in preparation).  Rising Social Epidemics: Avian flu, SARS & AIDS:  Confronting the infrastructural deficiencies of the public health system in China.  International Journal of Health Services.
25.    Aruru M, & Salmon J W. (2015, in preparation).   Unrestricted and Uninhibited UV exposure: A case for effective policy standards over the Indoor Tanning Industry.   American Journal of Public Health